The stock of Medical Facilities Corp (TSE:DR) is a huge mover today! About 103,473 shares traded hands or 11.68% up from the average. Medical Facilities Corp (TSE:DR) has risen 13.53% since April 8, 2016 and is uptrending. It has outperformed by 8.55% the S&P500.
The move comes after 8 months negative chart setup for the $513.92M company. It was reported on Nov, 14 by Barchart.com. We have $16.14 PT which if reached, will make TSE:DR worth $41.11M less.
Medical Facilities Corp (TSE:DR) Ratings Coverage
Out of 2 analysts covering Medical Facilities Corp (TSE:DR), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. $25 is the highest target while $17.50 is the lowest. The $19.88 average target is 13.34% above today’s ($17.54) stock price. Medical Facilities Corp has been the topic of 5 analyst reports since August 14, 2015 according to StockzIntelligence Inc. The stock of Medical Facilities Corp (TSE:DR) has “Buy” rating given on Friday, October 7 by TD Securities. TD Securities maintained the shares of DR in a report on Friday, November 11 with “Buy” rating. National Bank Canada maintained Medical Facilities Corp (TSE:DR) rating on Monday, August 17. National Bank Canada has “Sector Perform” rating and $17.50 price target.
Medical Facilities Corporation is a Canada company, which owns interests in over six entities , approximately five of which either own a specialty surgical hospital (SSH) or an ambulatory surgery center (ASC). The company has a market cap of $513.92 million. The Company’s Centers offer facilities, such as staff, surgical materials and supplies, and other support necessary for scheduled surgical, pain management, imaging and diagnostic procedures. It currently has negative earnings. The Centers focus on clinical specialties, such as orthopedic, neurosurgery, pain management and other non-emergency elective procedures.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.